新尿路血管造影剤DR 108の泌尿器科領域における使用経験 (コンレイ400(特集))
スポンサーリンク
概要
- 論文の詳細を見る
"DR 108 ", a new contrast medium, was used for sixteen excretory pyelographies and twelve renal arteriographies, and the following results were obtained. 1) In excretory pyelography, 19 out of 23 normal kidneys showed pyelograms of satisfactory visualization and clearity. When compared with Diatrizoate (76%) as to visualization on the same kidney, "DR 108" was rather superior to Diatrizoate except in the cases with obesity or without the ureteral compression. 2) Out of twelve renal arteriographies, the interlobar and arcuate arteries were clearly visualized in ten. When compared with Diatrizoate, rather quick transition from nephrogram to pyelogram was observed. 3) Intravascular injection of "DR 108" was much easier than the other contrast media ever used. This is an excellent aspect of this medium, because requirements such as practical usefulness and good visualization of renal arteriograms are satisfied. 4) Although vascular pain was rather frequently complained in renal arteriography, it was noteworthy that no side effects such as nausea and vomiting were observed at all in excretory pyelography.
- 泌尿器科紀要刊行会の論文
泌尿器科紀要刊行会 | 論文
- MVAC療法後の転移性尿路上皮癌に対するGemcitabine, Docetaxel, Carboplatin併用化学療法の検討
- Grade 3 Ta-1表在性膀胱癌に対する膀胱温存治療
- 腹腔鏡下に摘出した後腹膜神経線維腫の1例
- 移植腎生検による腎内動脈瘤破裂の1例
- Modified M-VAC療法後に残存腫瘍切除を施行した進行尿路上皮癌患者の治療成績